Meloxicam Tablet
Product Images NDC 0615-8124

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Meloxicam (NDC 0615-8124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Meloxicam 8040 8124 Cipla 1

FDA Label Image

Meloxicam 8040 8124 Cipla 2

This is a package of Meloxicam tablets, USP, 7.5mg manufactured by Cipla Pharmaceuticals and distributed by Vanguard. The package contains 30 tablets and includes information about dosage, storage, and protection against moisture. The lot number of the tablets is 8040 or 5080. The tablets are available for institutional use only.*

FDA Label Image

Meloxicam 8040 8124 Cipla 3

This is a label of Meloxicam, a tablet of 7.5mg, packaged by Vangard in Glasgow, KY 42141, and with LOT 8040. The medication is stored at 20-25°C and dispensed in a tightly closed container to protect from moisture. The description also includes dosage information and NDC identifier.*

FDA Label Image

Meloxicam 8040 8124 Cipla 4

This is a label for Meloxicam Tabs USP, a medication that contains 15mg of the active ingredient meloxicam. The label includes the product lot number and expiration date, as well as the manufacturer (Cipla) and packaging information. Storage instructions are provided, and the label is intended for institutional use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.